Latest in Finance

DNA Script and GE Healthcare awarded $26m ARPA-H funding to scale cell-free DNA bioproduction

The pair will combine DNA Script's EDS technology with GE HealthCare's DNA scaling technology to create a faster, more flexible manufacturing process for cell-free DNA as the use of personalised and time-sensitive genetic medicines grows

Find out more
DNA Script and GE Healthcare awarded $26m ARPA-H funding to scale cell-free DNA bioproduction

Loftware and RiseNow partner to strengthen supply chain traceability and compliance in healthcare settings

Loftware and RiseNow partner to strengthen supply chain traceability and compliance in healthcare settings

The alliance pairs Loftware's SAP-integrated product identification platform with RiseNow's procurement and supply chain advisory services, delivering end-to-end...
See more
Ratio Therapeutics raises $70m to expand radiopharmaceutical manufacturing

Ratio Therapeutics raises $70m to expand radiopharmaceutical manufacturing

The Series C financing will support clinical development of Ratio’s Ac-225 radiotherapeutic pipeline and expansion of its radiopharmaceutical manufacturing infrastructure
AstraZeneca-BMS $400bn merger could reshape US pharma manufacturing

AstraZeneca-BMS $400bn merger could reshape US pharma manufacturing

A potential AstraZeneca acquisition of Bristol Myers Squibb would create a near-$400bn pharma giant, combining major oncology portfolios and extensive US manufacturing operations
Clean Cells expands biopharma analytics with Anaquant acquisition

Clean Cells expands biopharma analytics with Anaquant acquisition

The purchase adds mass spectrometry-based protein characterisation and HCP analysis to Clean Cells’ GMP testing platform, creating an end-to-end analytical offering for biologics developers
Qureight raises $20m Series B to expand AI imaging platform into asthma, pulmonary hypertension and bronchiectasis

Qureight raises $20m Series B to expand AI imaging platform into asthma, pulmonary hypertension and bronchiectasis

The Molten Ventures-led round funds a 3D chest imaging Foundation Model laboratory and commercial expansion, building on Qureight's established lung fibrosis CRO capabilities across a $27.5bn clinical trials market.
Celonic and Leukocare to help clients with complex biologics and advanced drug product profiles

Celonic and Leukocare to help clients with complex biologics and advanced drug product profiles

Celonic and Leukocare partner to combine bioprocessing and GMP manufacturing with data-driven formulation expertise for complex biologics
ProBioGen and VarmX announce collaboration for advanced cell line development

ProBioGen and VarmX announce collaboration for advanced cell line development

This partnership builds upon ProBioGen's extensive expertise in coagulation factor development, including successful programmes with Factor VII and Factor VIII therapeutics
Mechitronic acquires Lambert to strengthen pharma and medtech assembly platform

Mechitronic acquires Lambert to strengthen pharma and medtech assembly platform

The €20m deal adds Lambert's 50-year complex assembly and filling automation expertise in Tadcaster to Mechitronic's 15-brand network, strengthening the group's UK pharma presence as it targets €285m aggregate revenue
Safety in pharmaceutical manufacturing: why a trusted partner makes all the difference

Safety in pharmaceutical manufacturing: why a trusted partner makes all the difference

By taking a three-tiered approach to protecting patients and personnel and ensuring plant compliance, GEA adopts a consultative approach to helping its customers navigate the responsibilities of pharmaceutical manufacturing safety with confidence

Latest posts in Finance

Samsung Biologics to acquire PolyPeptide in $1.8bn deal

Samsung Biologics to acquire PolyPeptide in $1.8bn deal

The manufacturer is set to acquire peptide CDMO PolyPeptide for CHF 1.46bn, expanding its manufacturing capabilities into peptide APIs and strengthening its global footprint across the US, Europe and India
Mission Therapeutics divests acute kidney injury drug MTX652 in $292m Dimerix deal

Mission Therapeutics divests acute kidney injury drug MTX652 in $292m Dimerix deal

Cambridge-based biotech Mission Therapeutics has divested its Phase II-ready USP30 inhibitor MTX652 to renal specialist Dimerix in a deal worth up to $292m, allowing the company to accelerate its Parkinson’s disease pipeline
Johnson & Johnson to spend up to $750m restructuring pharmaceutical supply chain

Johnson & Johnson to spend up to $750m restructuring pharmaceutical supply chain

The pharma giant is consolidating parts of its manufacturing network as it advances a $55bn US investment programme aimed at expanding domestic production of advanced medicines
Leica Biosystems acquires StatLab to strengthen anatomic pathology and AI-enabled cancer diagnostics

Leica Biosystems acquires StatLab to strengthen anatomic pathology and AI-enabled cancer diagnostics

The deal adds StatLab's 50-year histology workflow portfolio to Leica Biosystems' computational pathology platform, supporting laboratory standardisation for AI-driven cancer diagnostics at scale
Inflexion acquires German medical consumables specialist Primed to accelerate global expansion

Inflexion acquires German medical consumables specialist Primed to accelerate global expansion

The private equity firm has agreed to acquire Germany's Primed Group, backing investment in medical consumables manufacturing, sterilisation services and international growth
Brenntag Pharma signs exclusive European distribution agreement with Evonik for REXIM GMP amino acids

Brenntag Pharma signs exclusive European distribution agreement with Evonik for REXIM GMP amino acids

Agreement strengthens Brenntag’s position in biopharma and API markets in Europe
Codis acquires Catalent's Nottingham site to become Europe's leading end-to-end spray dry provider

Codis acquires Catalent's Nottingham site to become Europe's leading end-to-end spray dry provider

The deal pairs Nottingham's OSD development and clinical supply expertise with Codis' commercial-scale Haverhill facility, offering pharma partners an integrated ASD development-to-manufacture pathway within a single quality system
Novartis to acquire ADC biotech Myricx Bio for $1.5bn

Novartis to acquire ADC biotech Myricx Bio for $1.5bn

The pharma giant will add the biotech's novel NMTi payload platform to its roster, which may have potential in multiple solid tumour settings and overcome issues that have troubled ADC therapies, such as payload resistance and tolerability
AlzeCure enters an outlicensing and collaboration agreement with QuantumCell ApS

AlzeCure enters an outlicensing and collaboration agreement with QuantumCell ApS

AlzeCure will receive an upfront payment of $12m, with additional development and commercial milestone payments and royalties
Icosagen completes €45m expansion to bring discovery, development and GMP manufacturing under one roof

Icosagen completes €45m expansion to bring discovery, development and GMP manufacturing under one roof

The expansion enables Icosagen to support biotechnology and biopharmaceutical companies globally across discovery, developability assessment, CMC development and Phase I/II GMP manufacturing within one integrated organisation at a single site
Adragos signs agreement with Towa Pharmaceutical to supply off-patent medicines

Adragos signs agreement with Towa Pharmaceutical to supply off-patent medicines

Adragos Pharma Kawagoe KK has announced the signing of an agreement with Towa Pharmaceutical Co., Ltd, to establish a strategic collaboration aimed at ensuring the stable supply of off-patent pharmaceuticals

Sponsor content

Digitalisation: more space for research and development in Salzburg, Austria

Digitalisation: more space for research and development in Salzburg, Austria

COPA-DATA is investing €15 million in the project, underlining its long-term commitment to Salzburg and Austria as a location for technology, research and innovation
Gerresheimer is selling Centor and its global Primary Packaging Plastics business to Apax Funds

Gerresheimer is selling Centor and its global Primary Packaging Plastics business to Apax Funds

Significant optimisation of the capital and financing structure through expected cash inflows, meaningfully decreasing leverage
LogiPharma Digital Supply Chain Connect announces 2026 agenda for pharma supply chain summit

LogiPharma Digital Supply Chain Connect announces 2026 agenda for pharma supply chain summit

Exclusive Frankfurt event to bring together senior pharma supply chain leaders, digital transformation specialists and technology partners
Lonza and Engitix announce license agreement to advance targeted ADC Development

Lonza and Engitix announce license agreement to advance targeted ADC Development

Lonza grants Engitix target-specific license for GlycoConnect, HydraSpace and SYNtecan E linker-payload technologies for ADC development
Gerresheimer publishes 2025 annual and consolidated financial statements

Gerresheimer publishes 2025 annual and consolidated financial statements

Stable revenue in a challenging financial year
Next expansion milestone achieved: SCHOTT Pharma opens production facility in Serbia to strengthen competitiveness in Europe

Next expansion milestone achieved: SCHOTT Pharma opens production facility in Serbia to strengthen competitiveness in Europe

After a double-digit million euro investment and less than 1.5 years of construction, SCHOTT Pharma opens new manufacturing site in Jagodina, Serbia. Production capacity...
Almac group delivers record year of growth

Almac group delivers record year of growth

Revenue rises to £1.1 billion as profit increases 16% and workforce expands to more than 7,900 amid continued global investment programme
Andelyn Biosciences launches LVV Curator platform, bringing proven viral vector platform pedigree to Lentiviral Vector manufacturing for cell therapies

Andelyn Biosciences launches LVV Curator platform, bringing proven viral vector platform pedigree to Lentiviral Vector manufacturing for cell therapies

New platform leverages the established Curator platform methodology to industrialise Lentivirus processes from concept to clinic
Adragos Pharma appoints Kostas Rengis as Chief Executive Officer

Adragos Pharma appoints Kostas Rengis as Chief Executive Officer

Munich, Germany – May 7th, 2026 – Adragos Pharma, a global contract development and manufacturing organisation (CDMO), today announced the appointment of Konstantinos...
Syngene strengthens leadership team with two key appointments to support next phase of growth

Syngene strengthens leadership team with two key appointments to support next phase of growth

Abhijit Zutshi joins as CCO and Maninder Kapoor Puri as CHRO. India/U.S./UK, 1 May 2026: Syngene International, a global contract research, development, and manufacturing...
Former Catalent Chair and CEO George Fotiades joins eXmoor Pharma board as Chair

Former Catalent Chair and CEO George Fotiades joins eXmoor Pharma board as Chair

Angela Osborne steps back from operational duties and continues as Founder and Board Director, providing strategic continuity as eXmoor builds the leadership depth to...
Lonza completes transformation to pure-play CDMO with agreement to divest Capsules & Health Ingredients

Lonza completes transformation to pure-play CDMO with agreement to divest Capsules & Health Ingredients

Sale of CHI business to Lone Star funds marks final step in Lonza’s strategic shift to a focused CDMO model